Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ROKA

(ROKA) (ROKA) Stock Price, News & Analysis

(ROKA) logo

About (ROKA) Stock (NASDAQ:ROKA)

Advanced Chart

Key Stats

Today's Range
$0.65
$0.69
50-Day Range
N/A
52-Week Range
$0.60
$6.20
Volume
242,292 shs
Average Volume
371,374 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Receive ROKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROKA) and its competitors with MarketBeat's FREE daily newsletter.

ROKA Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Headlines

ROKA Stock Analysis - Frequently Asked Questions

(ROKA) (NASDAQ:ROKA) released its quarterly earnings results on Thursday, May, 11th. The medical research company reported ($1.53) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.19) by $0.34. The medical research company had revenue of $2.04 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ROKA) investors own include Credit Suisse High Yield Bond Fund (DHY), Western Asset High Income Fund II (HIX), PIMCO Corporate & Income Opportunity Fund (PTY), ASML (ASML), Corbus Pharmaceuticals (CRBP), STAG Industrial (STAG) and Twitter (TWTR).

Company Calendar

Last Earnings
5/11/2017
Today
5/21/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ROKA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:ROKA) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners